866-997-4948(US-Canada Toll Free)

Investigation Report on China Sertraline Market, 2010-2019

Published By :

China Research and Intelligence Co., Ltd. (CRI)

Published Date : Jul 2015

Category :

Manufacturing, Packaging & Detailing

No. of Pages : 35 Pages


According to WHO, depression, an affective mental disorder, is quite common with an incidence of 3-5%. Currently, the number of depression patients has exceeded 90 million in China and still keeps increasing. It is expected that by 2020, depression will become the second biggest threat to human health.

Developed by Pfizer, Inc. in the early 1990s, sertraline (sertraline dydrochloride) has entered many countries like the US, European countries and Japan to treat dysthymi and has brought in an annual sales value of over 1 billion all over the world. As the newest product of selective serotonin reuptake inhibitor (SSRI), sertraline can help improve organism ability, reduce symptoms of depression like distress and alleviate persistent fatigue and anxiety. As one of the three SSRI drugs with certain efficacy (the other two being fluoxetine and paroxetine), sertraline has been widely used for the treatment of depressive disorder and obsessive-compulsive disorder.

According to CRI’s market survey, sertraline keeps growing with annual sales value rising from CNY 20 million in 2005 to CNY 148 million in 2014 and CAGR during this period reaching 23.50% after it entered China in 1996. Pfizer, Inc., Zhejiang Jingxin Pharmaceutical Co., Ltd, Tianjin Huajin Pharmaceutical Factory, Guangdong P.D. Pharmaceutical Co., Ltd and Chengdu Leer Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which Pfizer, Inc. had the largest market share of about 83% for sales value in 2014.

With the increased mental pressure brought about by economic development and lifestyle change, the number of depression patients keeps growing too. Therefore, the market size of sertraline is expected to expand in the next few years in China.

Readers can get at least the following information from this report:
  • market size of sertraline in China
  • competitive landscape of sertraline in Chinese market
  • price of sertraline made by different enterprises in China
  • market outlook of sertraline in China
suggests the following groups of people purchase this report:
  • manufacturers of antidepressant
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

1 Related Concepts of Sertraline
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Sertraline in China
2.1 Patent and Approval Status of Sertraline in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Sertraline in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Sertraline in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Sertraline in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Sertraline in Chinese Hospitals in 2014
6.1 Aventis Pharma Group (Trade Name: Quyou)
6.2 Shanghai New Asia Pharmaceutical Co., Ltd
6.3 Tianjin Huajin Pharmaceutical Factory (Trade Name: Xitongjing)
6.4 Zhejiang Jingxin Pharmaceutical Co., Ltd (Trade Name: Weitating)
6.5 Zhejiang Huahai Pharmaceutical Co., Ltd (Trade Name: Leyuan)
6.6 Pfizer, Inc. (US) (Trade Name: Zoloft)

7 Major Manufacturers of Sertraline in Chinese Market, 2010-2014
7.1 Zhejiang Jingxin Pharmaceutical Co., Ltd
7.2 Tianjin Huajin Pharmaceutical Factory
7.3 Guangdong P.D. Pharmaceutical Co., Ltd
7.4 Zhejiang Huahai Pharmaceutical Co., Ltd
7.5 Pfizer, Inc.

8 Market Ooutlook of Sertraline in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Table


Chart Approval Information of Sertraline in China
Chart Sales Status of Sertraline in China
Chart Sales Value of Sertraline in China, 2010-2014
Chart Sales Value of Sertraline in Some Regions in China, 2010-2014
Chart Sales Volume of Sertraline in China, 2010-2014
Chart Sales Volume of Sertraline in Some Regions in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Sertraline for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Sertraline Made by Pfizer (US) in China, 2010-2014
Chart Sales Value and Market Share of Sertraline Made by Zhejiang Jingxin in China, 2010-2014
Chart Sales Value and Market Share of Sertraline Made by Guangdong P.D. in China, 2010-2014
Chart Sales Value and Market Share of Sertraline Made by Chengdu Leer in China, 2010-2014
Chart Sales Value and Market Share of Sertraline Made by Tianjin Huajin in China, 2010-2014
Chart Sales Value and Market Share of Sertraline Tablets in China, 2010-2014
Chart Sales Value and Market Share of Sertraline Capsules in China, 2010-2014
Chart Sales Volume and Market Share of Sertraline Tablets in China, 2010-2014
Chart Sales Volume and Market Share of Sertraline Capsules in China, 2010-2014
Chart Price of Sertraline Made by Aventis Pharma Group in Some Chinese Cities in 2014
Chart Price of Sertraline Made by Shanghai New Asia Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Sertraline Made by Tianjin Huajin Pharmaceutical Factory in Some Chinese Cities in 2014
Chart Price of Sertraline Made by Zhejiang Jingxin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Sertraline Made by Zhejiang Huahai Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Sertraline Made by Pfizer, Inc. (US) in Some Chinese Cities in 2014

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *